Julien Masliah Planchon, Ph.D

Julien is a PharmD, PhD practitioner in the genetic department of the Curie Institute in Paris specialising in the genetic of paediatric tumours and notably brain tumours. He is also involved in the local molecular tumour board dedicated to identify targeted therapy based on molecular analysis.

Most relevant recent publications

A malignant choroid plexus tumour with prevailing immature blastematous elements. Tauziède-Espariat A, Pagès M, Masliah-Planchon J, Bourdeaut F, Doz F, Beccaria K, Boddaert N, Hasty L, Lechapt E, Thomas C, Paulus W, Varlet P, Hasselblatt M. Neuropathol Appl Neurobiol. 2021

Prognostic value of tumor mutational burden in patients with oral cavity squamous cell carcinoma treated with upfront surgery. Moreira A, Poulet A, Masliah-Planchon J, Lecerf C, Vacher S, Larbi Chérif L, Dupain C, Marret G, Girard E, Syx L, Hoffmann C, Jeannot E, Klijanienko J, Guillou I, Mariani O, Dubray-Vautrin A, Badois N, Lesnik M, Choussy O, Calugaru V, Borcoman E, Baulande S, Legoix P, Albaud B, Servant N, Bieche I, Le Tourneau C, Kamal M. ESMO Open. 2021

SMARCA4-deficient rhabdoid tumours show intermediate molecular features between SMARCB1-deficient rhabdoid tumours and small cell carcinomas of the ovary, hypercalcaemic type. Andrianteranagna M, Cyrta J, Masliah-Planchon J, Nemes K, Corsia A, Leruste A, Holdhof D, Kordes U, Orbach D, Corradini N, Entz-Werle N, Pierron G, Castex MP, Brouchet A, Weingertner N, Ranchère D, Fréneaux P, Delattre O, Bush J, Leary A, Frühwald MC, Schüller U, Servant N, Bourdeaut F. J Pathol. 2021